| Literature DB >> 31289303 |
Yan Chen1, Jianwei Wang1, Qinghuang Ye1, Zhijiang Wang1, Weihong Weng2, Jinhui Zhu3.
Abstract
Fast-track surgery is claimed to reduce medical morbidity, eliminate the hospitalization needs, and shorten the convalescence period. Intraoperative bleeding as the main complication is also the primary cause of conversion from laparoscopic to open splenectomy. Intraoperative blood salvage can reduce transfusion requirements, decrease the conversion rate to open, and promote fast-tracking in laparoscopic splenectomy (LS). From November 2007 through December 2016 we collected medical data of 115 LS patients. There were three groups: 54 patients receiving routine care (we marks them as Group RT), 33 patients with fast-track care (Group FT), and 28 receiving fast-track care receiving intraoperative splenic blood salvage and autotransfusion (Group FT + ISBS). These medical data are comprised of included three phases (pre-, intra-, and postoperative). There were significant differences (P < 0.05) between RT, FT, and FT + ISBS groups. The hemoglobin level in Group FT + ISBS was significantly higher than in Group RT and Group FT. Comparing the duration of hospital stay of 3 groups, Group RT stayed for a significantly longer time than Group FT and Group FT + ISBS, Group FT + ISBSmuch shorter than Group FT. Comparing the hospitalization expense, GroupFT + ISBS significantly expended less than Group RT and Group FT. Our study shows that laparoscopic splenectomy with fast-track care is feasible, effective, and safe for patients who require splenectomy. Fast-tracking with intraoperative blood salvage improved the fast-track laparoscopic splenectomy procedure.Entities:
Mesh:
Year: 2019 PMID: 31289303 PMCID: PMC6617455 DOI: 10.1038/s41598-019-45865-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Patient characteristics by surgery groups.
Preoperative phase Patients age, gender, Child-Pugh class (A:B), spleen longitudinal diameter (cm), perioperative blood test included haemoglobin (Hb), AST, ALT. |
Intraoperative phase operation time (minites), volume of intraoperative blood loss and blood autotransfusion, the numbers of conversion to open |
Postoperative phase the numbers of postoperative fever (>38.5 °C), the others complications including pulmonary infection, tender pancreatic leakage, subphrenic abscess, injure of colon, postoperative blood test included haemoglobin (Hb), Tbil, Ibil, AST, ALT, Hb increase, hospital stay, hospitalization expenses. |
Perioperative care in FT surgery.
Preoperative Phase Preoperative risk assessment for the special surgery Information to all the relative nurses, doctors and patients Fluid optimization |
Alcohol/smoking abstinence No bowel preparation Modern fasting guidelines:oral glucose fluid 2 h before surgery |
Intraoperative Phase Fluid optimisation (avoid hypovolaemia and crystalloid excess) :2000ml-2500ml/day in the day of surgery Regional anaesthesia:transabdominal pain block before the end of general anaesthesia Type of incision:horizontal Short-acting opioids |
Postoperative Phase Multimodal analgesia:intravenous, by mouth. Anti-emetic and anti-ileus prophylaxis Revise use of drains, tubes, catheters, monitoring, etc. Thromboembolic prophylaxis Early oral nutrition and ambulation:drink water 2 h after surgery;fluid and ambulation in the day one after surgery Daily care maps, well-defined discharge criteria Rehabilitation plan |
Figure 1Blood collected from the freed spleen in a hard bag were transferred to an autotransfusion device via a vacuum extractor.
Patient characteristics by surgery groups.
| Treatment group | RT | FT | FT + ISBS |
|
|
|
|---|---|---|---|---|---|---|
| Number of patients, n | 54 | 33 | 28 | / | / | / |
| Age, yr (mean ± SD) | 43.5 ± 6.7 | 47.1 ± 7.3 | 45.4 ± 5.5 | NS | NS | NS |
| Gender ratio,(F:M) | 34:20 | 23:10 | 19:9 | NS | NS | NS |
| Child-Pugh class (A:B) | 19:35 | 8:24 | 6:22 | NS | NS | NS |
| Spleen longitudinal diameter, cm | 20.4 ± 3.7 | 21.8 ± 4.5 | 22.7 ± 5.2 | NS | NS | NS |
| Hb, g/L | 9.6 ± 0.9 | 9.3 ± 1.1 | 8.9 ± 1.4 | NS | NS | NS |
| TBil, μmol/L | 36.5 ± 7.6 | 40.6 ± 7.3 | 37.9 ± 8.7 | NS | NS | NS |
| IBil, μmol/L | 27.3 ± 5.7 | 30.1 ± 7.7 | 28.5 ± 7.9 | NS | NS | NS |
| AST, U/L | 235.2 ± 93.6 | 259.7 ± 80.5 | 190.1 ± 100.1 | NS | NS | NS |
| ALT, U/L | 472.1 ± 174.5 | 500.1 ± 220.5 | 450.6 ± 191.2 | NS | NS | NS |
Haemoglobin = Hb; F = female; M = male;TBil = Total bilirubin; IBil = Indirect bilirubin; AST = glutamic oxalacetic transaminase; ALT = glutamic-pyruvic transaminase; NS = not significant.
P FT group comparring to TR group, <0.05 has statistical significance*;
PFT + ISBS group comparring to RT group, <0.05 has statistical significance†;
PFT + ISBS group comparring to FT group, <0.05 has statistical significance§.
Operative and complication data.
| Treatment group | RT | FT | FT + ISBS |
|
|
|
|---|---|---|---|---|---|---|
| Operative time, h | 2.8 ± 0.7 | 3.0 ± 1.1 | 2.9 ± 0.9 | NS | NS | NS |
| Blood loss, ml | 95.0 ± 40.5 | 100.5 ± 35.5 | 80.5 ± 32.5 | NS | NS | NS |
| Volume of blood autotransfused (ml) | 0 | 0 | 500.2 ± 160.5 | / | / | / |
| Conversion to open, n (n%) | 2 (3.7%) | 0 | 1 (3.6%) | NS | NS | NS |
|
| ||||||
| Postoperative fever (>38.5 °C), n (n%) | 9 (16.7%) | 4 (12.1%) | 5 (17.9%) | NS | NS | NS |
| Others, n (n%) | 4 (7.4%) | 2 (6.0%) | 1 (3.61%) | NS | NS | NS |
Others including pulmonary infection, tender pancreatic leakage, subphrenic abscess, injure of colon.
P FT group comparring to TR group, < 0.05 has statistical significance*;
PFT + ISBS group comparring to RT group, < 0.05 has statistical significance†;
PFT + ISBS group comparring to FT group, < 0.05 has statistical significance§.
Postoperative data of surgery groups.
| Treatment group | RT | FT | FT + ISBS |
|
|
|
|---|---|---|---|---|---|---|
| Hb, g/L | 9.3 ± 0.7 | 9.4 ± 0.9 | 11.2 ± 1.1 | NS | <0.05† | <0.05§ |
| TBil, μmol/L | 37.5 ± 5.6 | 39.2 ± 7.1 | 38.2 ± 6.5 | NS | NS | NS |
| IBil, μmol/L | 27.8 ± 5.1 | 29.8 ± 6.7 | 29.6 ± 7.7 | NS | NS | NS |
| AST, U/L | 255.2 ± 99.2 | 249.2 ± 86.1 | 220.1 ± 80.8 | NS | NS | NS |
| ALT, U/L | 452.1 ± 175.3 | 488.7 ± 251.4 | 430.6 ± 186.5 | NS | NS | NS |
| Hb increase (1d), g/L | 0.5 ± 0.2 | 0.6 ± 0.4 | 2.3 ± 1.0 | NS | <0.05† | <0.05§ |
| Hb increase (3d) | 0.6 ± 0.3 | 0.5 ± 0.2 | 2.5 ± 0.8 | NS | <0.05† | <0.05§ |
| Hospital stay, d | 8.4 ± 2.2 | 6.7 ± 2.8 | 5.4 ± 1.3 | <0.05* | <0.05† | <0.05§ |
| Hospitalization expenses, RMB (thousand) | 66.5 ± 21.5 | 53.5 ± 16.8 | 41.2 ± 13.6 | <0.05* | <0.05† | <0.05§ |
Haemoglobin = Hb; Hb increase = Hb (postoperaion) - Hb (preoperation); F = female; M = male; TBil = Total bilirubin; IBil = Indirect bilirubin; AST = glutamic oxalacetic transaminase; ALT = glutamic-pyruvic transaminase; NS = not significant.
P FT group comparring to RT group, <0.05 has statistical significance*;
PFT + ISBS group comparring to RT group, <0.05 has statistical significance†;
PFT + ISBS group comparring to FT group, <0.05 has statistical significance§.